논문 상세보기

5-Fluorouracil에 의한 뇌병증을 경험한 직장암 환자에서 Capecitabine으로 성공적으로 치료한 1예

Successful Treatment with Capecitabine after a History of 5-Fluorouracil Induced Encephalopathy in a Patient with Rectal Cancer

  • 언어KOR
  • URLhttps://db.koreascholar.com/Article/Detail/240526
서비스가 종료되어 열람이 제한될 수 있습니다.
The Medical Journal of Chosun University (조선대학교 의대논문집)
조선대학교 의학연구원 (Institute of Medical Science, Chosun University)
초록

Capecitabine is a prodrug of a 5-fluorouracil (5-FU) that is converted to 5-FU inside the tumor cells. Here, we report a case of 5-FU induced encephalopathy which was subsequently treated with capecitabine without any neurologic complication. A 76-year-old man with rectal adenocarcinoma received chemotherapy, which consisted of 5-FU, leucovorin and oxaliplatin after resection of the primary and metastatic masses. Confusion and agitation were observed during the 2nd cycle of chemotherapy and reappeared during 4th cycle. Both events were completely disappeared within a few days. Capecitabine was administered for 4 cycles without any neurologic toxicity. Capecitabine could be an alternative in patients experiencing 5-FU induced encephalopathy.

저자
  • 신진호(서울특별시 서울의료원 내과) | Jin Ho Shin
  • 정연상(서울특별시 서울의료원 내과) | Yeon Sang Jeong
  • 조진경(서울특별시 서울의료원 내과) | Jin Kyeong Cho
  • 김민성(서울특별시 서울의료원 내과) | Min Sung Kim
  • 박성재(서울특별시 서울의료원 내과) | Sung Jae Park
  • 전현정(서울특별시 서울의료원 내과) | Hyun Jung Jun
  • 오소연(서울특별시 서울의료원 내과) | So Yeon Oh Corresponding author